Peripheral Vascular Devices Market Report Suite - United States - 2020-2026 - MedSuite

Peripheral Vascular Devices Market Report Suite - United States - 2020-2026 - MedSuite

Throughout this medical market research, iData Research analyzed 67 peripheral vascular companies across the United States and utilized their comprehensive methodology to understand the Market Sizes, Unit Sales, ASPs, Company Market Shares, and to create accurate forecasts.

While this MedSuitereport contains all of the US Peripheral Vascular market analysis, each of the market segments is also available as stand-alone MedCorereports. Additionally, this research includes a peripheral vascular procedure volume analysis which can also be purchased as a separate report, MedPro.

Markets Covered

  • Procedure Volumes for the US Peripheral Vascular market – MedPro
  • Peripheral Vascular Stent Market - MedCore
  • Venous Stent Market - MedCore
  • PTA Balloon Catheter Market - MedCore
  • Drug-Coated Balloon Market - MedCore
  • Atherectomy Device Market - MedCore
  • Intravascular Lithotripsy Market - MedCore
  • Chronic Total Occlusion Device Market - MedCore
  • Surgical Graft Market - MedCore
  • Stent Graft Market - MedCore
  • Embolic Protection Device Market - MedCore
  • Peripheral Thrombus Management Device Market- MedCore
  • Inferior Vena Cava Filter and Retrieval Device Market- MedCore
  • Carotid Shunt Market- MedCore
  • Transcarotid Artery Revascularization Market- MedCore
  • Diagnostic & Interventional Catheter Market- MedCore
  • Introducer Sheath Market- MedCore
  • Vascular Closure Device Market- MedCore
  • Transcatheter Embolization Device Market- MedCore
  • Peripheral IVUS Catheter Market- MedCore
US Peripheral Vascular Devices Market Insights

One of the greatest limitations in this market is the pricing pressure that is occurring within the office-based lab (OBL) setting. Although these clinics have led to a significant increase in efficiency, reducing the average time for patients to be within a hospital, these settings are also incredibly price sensitive. It is typical that there is a 30% discount on devices sold to an OBL, relative to a hospital.

The release of the paclitaxel meta-analysis by Katsanos in late 2018 raised serious concern about the late mortality of drug-coated balloons (DCB) and drug-eluting stents (DES). At the start of 2019, the FDA announced that they would reexamine the safety of paclitaxel products in the peripheries. A large movement occurred shortly after, away from paclitaxel devices and towards more traditional devices. Although the FDA released a statement in August 2019 stating that they were not able to identify a late-mortality signal caused by paclitaxel use in the peripheries, hesitancy about the use of these devices remain.

Overall, the U.S. peripheral vascular device market was valued at $7.1 billion in 2019. This is expected to increase over the forecast period at a CAGR of 5.6% to reach $10.4 billion.

The full report suite on the U.S. market for peripheral vascular devices includes peripheral vascular stents, venous stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters. Many of these devices can be used for treating either coronary arterial disease or peripheral arterial disease (PAD). However, only devices used for peripheral procedures are included in this report.


EXECUTIVE SUMMARY
U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW
COMPETITIVE ANALYSIS
MARKET TRENDS
MARKET DEVELOPMENTS
PROCEDURE NUMBERS
PROCEDURE CODES INVESTIGATED
MARKETS INCLUDED
KEY REPORT UPDATES
VERSION HISTORY
RESEARCH METHODOLOGY
1.1.1 Step 1: Project Initiation & Team Selection
1.1.2 Step 2: Prepare Data Systems and Perform Secondary Research
1.1.3 Step 3: Preparation for Interviews & Questionnaire Design
1.1.4 Step 4: Performing Primary Research
1.1.5 Step 5: Research Analysis: Establishing Baseline Estimates
1.1.6 Step 6: Market Forecast and Analysis
1.1.7 Step 7: Identify Strategic Opportunities
1.1.8 Step 8: Final Review and Market Release
1.1.9 Step 9: Customer Feedback and Market Monitoring  
DISEASE OVERVIEW
2.1 BASIC ANATOMY
2.2 DISEASE TREATMENTS & DIAGNOSTICS
2.2.1 Aortic Aneurysms
2.2.2 Atherosclerosis
2.2.3 Peripheral Arterial Disease (PAD)
2.2.4 Deep Vein Thrombosis (DVT)
2.2.5 Pulmonary Embolism (PE)
2.3 PATIENT DEMOGRAPHICS
2.3.1 Aortic Aneurysms
2.3.2 Atherosclerosis
2.3.3 Peripheral Arterial Disease (PAD)
2.3.4 Deep Vein Thrombosis (DVT)
2.3.5 Pulmonary Embolism (PE)
PRODUCT ASSESSMENT
3.1 INTRODUCTION
3.2 PRODUCT PORTFOLIOS
3.2.1 Peripheral Vascular Stent
3.2.2 Venous Stent
3.2.3 Percutaneous Transluminal Angioplasty (PTA) Balloon
3.2.4 Drug-Coated Balloon
3.2.5 Atherectomy Device
3.2.6 Chronic Total Occlusion (CTO) Device
3.2.7 Intravascular Lithotripsy
3.2.8 Surgical Graft
3.2.9 Stent Graft
3.2.10 Embolic Protection Device
3.2.11 Peripheral Thrombus Management Device
3.2.12 Inferior Vena Cava Filter
3.2.13 Carotid Shunt
3.2.14 Diagnostic and Interventional Catheters
3.2.15 Diagnostic and Interventional Guidewire
3.2.16 Introducer Sheath
3.2.17 Vascular Closure Device (VCD)
3.2.18 Transcatheter Embolization Device
3.2.19 Peripheral IVUS Catheter
3.3 REGULATORY ISSUES AND RECALLS
3.3.1 Abbott
3.3.1.1 Carotid Shunt
3.3.1.2 Vascular Closure Device
3.3.2 Argon Medical
3.3.2.1 Introducer Sheaths
3.3.3 Arrow International
3.3.3.1 Introducer Sheaths
3.3.4 Atrium Medical
3.3.4.1 Peripheral Vascular Stent
3.3.5 BD
3.3.5.1 Inferior Vena Cava Filter
3.3.5.2 Introducer Sheaths
3.3.5.3 Stent Graft
3.3.6 Boston Scientific
3.3.6.1 Atherectomy Devices
3.3.6.2 Diagnostic and Interventional Catheters
3.3.6.3 Introducer Sheaths
3.3.6.4 Peripheral Thrombus Management Devices
3.3.7 Cardinal Health
3.3.7.1 Vascular Closure Devices
3.3.8 Cardiovascular System (C.S.I.)
3.3.8.1 Atherectomy Devices
3.3.9 Cook Medical
3.3.9.1 Diagnostic and Interventional Catheters
3.3.9.2 Introducer Sheaths
3.3.9.3 Inferior Vena Cava Filters
3.3.9.4 Peripheral Vascular Stents
3.3.9.5 Stent Grafts
3.3.10 Cordis (Cardinal Health)
3.3.10.1 Diagnostic and Interventional Catheters
3.3.10.2 Inferior Vena Cava Filters
3.3.10.3 Peripheral Stents
3.3.11 Endologix
3.3.11.1 Stent Grafts
3.3.12 Edwards Lifesciences
3.3.12.1 Chronic Total Occlusion Devices
3.3.13 Maquet
3.3.13.1 PTA Balloons
3.3.14 Medtronic
3.3.14.1 Carotid Shunts
3.3.14.2 Diagnostic and Interventional Catheters
3.3.14.3 PTA Balloon Catheters
3.3.14.4 Peripheral Stents
3.3.14.5 Stent Grafts
3.3.14.6 Transcatheter Embolization Devices
3.3.15 Spectranetics (Philips)
3.3.15.1 Atherectomy Devices
3.3.15.2 Chronic Total Occlusion Devices
3.3.16 Shockwave Medical, Inc.
3.3.16.1 Intravascular Lithotripsy
3.3.17 Terumo
3.3.17.1 Introducer Sheaths
3.3.17.2 PTA Balloon Catheters
3.3.18 Other Companies
3.3.18.1 Atherectomy Devices
3.3.18.2 Introducer Sheaths
3.3.18.3 PTA Balloon Catheters
3.3.18.4 Peripheral IVUS Catheters
3.3.18.5 Stent Grafts
3.3.18.6 Vascular Closure Devices (VCD)
3.4 CLINICAL TRIALS
3.4.1 Abbott
3.4.1.1 Peripheral Vascular Stent
3.4.1.2 Other Peripheral Vascular Related Studies
3.4.2 B. Braun
3.4.2.1 Diagnostic and Interventional Catheters
3.4.2.2 Peripheral Vascular Stent
3.4.3 Boston Scientific
3.4.3.1 Atherectomy Devices
3.4.3.2 Drug-Coated Balloons
3.4.3.3 Peripheral Vascular Stents
3.4.3.4 Other Peripheral Vascular Related Studies
3.4.3.5 Venous Stents
3.4.4 C.R. Bard (BD)
3.4.4.1 Diagnostic and Interventional Catheters
3.4.4.2 Drug-Coated Balloons
3.4.4.3 Venous Stents
3.4.4.4 Other Peripheral Vascular Related Studies
3.4.5 Cardinal Health
3.4.5.1 Other Peripheral Vascular Related Studies
3.4.6 Cook Medical
3.4.6.1 Drug-Eluting Stents
3.4.6.2 Inferior Vena Cava Filters
3.4.6.3 Peripheral Vascular Stents
3.4.6.4 Venous Stents
3.4.7 Cordis (Cardinal Health)
3.4.7.1 Peripheral Vascular Stents
3.4.8 Medtronic
3.4.8.1 Atherectomy Devices
3.4.8.2 Drug-Coated Balloons
3.4.8.3 Other Peripheral Vascular Related Studies
3.4.9 Merit Medical
3.4.9.1 Stent Grafts
3.4.10 Philips/Spectranetics
3.4.10.1 Atherectomy Devices
3.4.10.2 Peripheral IVUS Catheters
3.4.10.3 Spectranetics
3.4.10.3.1 Drug-Coated Balloons
3.4.10.3.2 Atherectomy Devices
3.4.11 Shockwave Medical, Inc.
3.4.11.1 Lithoplasty System
3.4.12 Surmodics
3.4.12.1 Drug-Coated Balloons
3.4.13 Terumo
3.4.13.1 Drug-Coated Balloons
3.4.13.2 Peripheral Vascular Stents
3.4.14 W.L. Gore
3.4.14.1 Peripheral Vascular Stents
3.4.14.2 Stent Grafts
3.4.14.3 Expandable Balloons
3.4.15 Other Companies
3.4.15.1 Carotid Shunt / Endarterectomy
3.4.15.2 Drug-Coated Balloons
3.4.15.3 Peripheral Vascular Stents
3.4.15.4 Other Peripheral Vascular Related Studies
U.S. PERIPHERAL VASCULAR DEVICE MARKET OVERVIEW
4.1 INTRODUCTION
4.1.1 Atherosclerosis
4.1.2 Peripheral Arterial Disease (PAD)
4.2 MARKET OVERVIEW
4.3 TREND ANALYSIS BY SEGMENT
4.4 DRIVERS AND LIMITERS
4.4.1 Market Drivers
4.4.2 Market Limiters
4.5 COMPETITIVE MARKET SHARE ANALYSIS
4.6 MERGERS AND ACQUISITIONS
4.7 COMPANY PROFILES
4.7.1 Abbott
4.7.2 Becton Dickinson (BD)
4.7.3 Boston Scientific
4.7.4 Cardinal Health
4.7.4.1 Cordis (Cardinal Health)
4.7.5 Cook Medical
4.7.6 Maquet
4.7.7 Medtronic
4.7.8 Teleflex
4.7.9 Terumo Interventional System (TIS)
4.7.10 W.L. Gore
4.8 SWOT ANALYSIS
4.8.1 Abbott
4.8.2 B. Braun
4.8.3 Boston Scientific
4.8.4 BD
4.8.5 Cardinal Health
4.8.6 Cook Medical
4.8.7 Integra Lifesciences
4.8.8 Maquet
4.8.9 Medtronic
4.8.10 Merit Medical
4.8.11 Phillips
4.8.12 Teleflex
4.8.13 Terumo
4.8.14 W.L. Gore
PROCEDURE NUMBERS
5.1 INTRODUCTION
5.2 PROCEDURES
5.2.1 Total Peripheral Vascular Procedures
5.2.2 Total Peripheral Vascular Procedures by Device Type, Indication, Intervention & Care Setting
5.2.2.1 Above-the-Knee Procedures
5.2.2.1.1 Above-the-Knee Stent Procedures
5.2.2.1.2 Above-the-Knee POBA Procedures by Care Setting
5.2.2.1.3 Above-the-Knee DCB Procedures by Care Setting
5.2.2.1.4 Above-the-Knee Atherectomy without Stent Procedures by Care Setting
5.2.2.1.5 Above-the-Knee Atherectomy with Stent Procedures by Care Setting
5.2.2.2 Below-the-Knee Procedures
5.2.2.2.1 Below-the-Knee Stent Procedures by Device Type
5.2.2.2.2 Below-the-Knee Stent Procedures by Care Setting
5.2.2.2.3 Below-the-Knee POBA Procedures by Care Setting
5.2.2.2.4 Below-the-Knee DCB Procedures by Care Setting
5.2.2.2.5 Below-the-Knee Atherectomy without Stent Procedures by Care Setting
5.2.2.2.6 Below-the-Knee Atherectomy with Stent Procedures by Care Setting
5.2.2.3 Iliac Procedures
5.2.2.3.1 Iliac Stent Procedures by Device Type
5.2.2.3.2 Iliac Stent Procedures by Care Setting
5.2.2.3.3 Iliac POBA Procedures by Care Setting
5.2.2.4 AV Access Procedures
5.2.2.4.1 AV Access Covered Stent Procedures by Care Setting
5.2.2.4.2 AV Access POBA Procedures by Care Setting
5.2.2.4.3 AV Access DCB Procedures by Care Setting
5.2.2.5 Renal Procedures
5.2.2.6 Carotid Procedures
5.2.3 Peripheral Vascular Stent Procedures
5.2.3.1 Peripheral Arterial Stent Procedures by Stent Type
5.2.3.1.1 Bare-Metal Stent Procedures
5.2.3.1.2 Covered Stent Procedures
5.2.3.1.3 Drug-Eluting Stent Procedures
5.2.4 Peripheral Venous Stent
5.2.5 PTA Balloon Catheter Procedures
5.2.6 Drug-Coated Balloon Procedures
5.2.6.1 Drug-Coated Balloon Procedures by Indication
5.2.7 Atherectomy Procedures
5.2.7.1 Atherectomy Procedures by Device Type
List of Charts
Chart 1 1: Peripheral Vascular Device Market by Segment, U.S., 2016 – 2026
Chart 1 2: Peripheral Vascular Device Market Overview, U.S., 2019 & 2026
Chart 4 1: Peripheral Vascular Device Market by Segment, U.S., 2016 – 2026
Chart 4 2: Peripheral Vascular Device Market Breakdown, U.S., 2019
Chart 4 3: Peripheral Vascular Device Market Breakdown, U.S., 2026
Chart 4 4: Growth Rates by Segment, Peripheral Vascular Device Market, U.S., 2017 – 2026
Chart 4 5: Leading Competitors, Peripheral Vascular Device Market, U.S., 2020
Chart 5 1: Peripheral Vascular Procedures by Type, U.S., 2016 – 2026
Chart 5 2: Stenting Procedures by Stent Type, U.S., 2016 – 2026
Chart 5 3: Bare-Metal Stent Procedures by Delivery Method, U.S., 2016 – 2026
Chart 5 4: Bare-Metal Stent Procedures by Indication, U.S., 2016 – 2026
Chart 5 5: Covered Stent Procedures by Indication, U.S., 2016 – 2026
Chart 5 6: Drug-Eluting Stent Procedures by Indication, U.S., 2016 – 2026
Chart 5 7: Peripheral Venous Stent Procedures, U.S., 2016 – 2026
Chart 5 8: PTA Balloon Catheter Procedures, U.S., 2016 – 2026
Chart 5 9: Drug-Coated Balloon Procedures by Indication, U.S., 2016 – 2026
Chart 5 10: Drug-Coated Balloon Procedures by Care Setting, U.S., 2016 – 2026
Chart 5 11: Atherectomy Procedures by Device Type, U.S., 2016 – 2026
Chart 5 12: Atherectomy Procedures by Indication, U.S., 2016 – 2026
Chart 5 13: Fem-Popliteal Artery Atherectomy Procedures by Type, U.S., 2016 – 2026
Chart 5 14: Infra-Popliteal Artery Atherectomy Procedures by Type, U.S., 2016 – 2026
Chart 5 15: Intravascular Lithotripsy Procedures by Indication, U.S., 2016 – 2026
Chart 5 16: CTO Device Procedures by Type, U.S., 2016 – 2026
Chart 5 17: Surgical Graft Procedures by Graft Material, U.S., 2016 – 2026
Chart 5 18: Surgical Graft Procedures by Indication, U.S., 2016 – 2026
Chart 5 19: Lower Limb Surgical Graft Procedures by Anatomy, U.S., 2016 – 2026
Chart 5 20: Aorta Repair Surgical Graft Procedures by Anatomy, U.S., 2016 – 2026
Chart 5 21: Endovascular Stent Graft Procedures by Type, U.S., 2016 – 2026
Chart 5 22: EVAR Procedures by Anatomy, U.S., 2019
Chart 5 23: EVAR Procedures by Complexity, U.S., 2016 – 2026
Chart 5 24: EVAR Procedures by Fenestration, U.S., 2016 – 2026
Chart 5 25: EVAR Procedures by Anesthesia Type, U.S., 2016 – 2026
Chart 5 26: EVAR Procedures by Gender, U.S., 2016 – 2026
Chart 5 27: TEVAR Procedures by Indication, U.S., 2019
Chart 5 28: TEVAR Procedures by Gender, U.S., 2016 – 2026
Chart 5 29: Embolic Protection Procedures by Type, U.S., 2016 – 2026
Chart 5 30: Peripheral Thrombus Management Procedures by Procedure Type, U.S., 2016 – 2026
Chart 5 31: Peripheral Thrombus Management Procedures by Indication, U.S., 2016 – 2026
Chart 5 32: Inferior Vena Cava Filter Procedures by Procedure Type, U.S., 2016 – 2026
Chart 5 33: Transcarotid Artery Revascularization Procedures, U.S., 2016 – 2026
Chart 5 34: Vascular Closure Procedures by Device Type, U.S., 2016 – 2026
Chart 5 35: Invasive Vascular Closure Procedures by Device Size, U.S., 2016 – 2026
Chart 5 36: Vascular Closure Procedures by Approach, U.S., 2016 – 2026
Chart 5 37: Transcatheter Embolization Procedures by Device Type, U.S., 2016 – 2026
Chart 5 38: Transcatheter Particle Embolization Procedures by Device Type, U.S., 2016 – 2026
Chart 5 39: Transcatheter Coil Embolization Procedures by Device Type, U.S., 2016 – 2026
Chart 5 40: Peripheral IVUS Procedures by Indication, U.S., 2016 – 2026
Chart 6 1: Peripheral Vascular Stent Market by Segment, U.S., 2016 – 2026
Chart 6 2: Peripheral Vascular Stent Market Breakdown, U.S., 2019
Chart 6 3: Peripheral Vascular Stent Market Breakdown, U.S., 2026
Chart 6 4: Total Bare-Metal Peripheral Arterial Stent Market, U.S., 2016 – 2026
Chart 6 5: Bare-Metal Stent Market by Indication, U.S., 2016 – 2026
Chart 6 6: Bare-Metal Carotid Stent Market, U.S., 2016 – 2026
Chart 6 7: Bare-Metal Renal Stent Market, U.S., 2016 – 2026
Chart 6 8: Bare-Metal Iliac Stent Market, U.S., 2016 – 2026
Chart 6 9: Bare-Metal Fem-Popliteal Stent Market, U.S., 2016 – 2026
Chart 6 10: Bare-Metal Infra-Popliteal Stent Market, U.S., 2016 – 2026
Chart 6 11: Bare-Metal Stent Market by Delivery Platform, U.S., 2016 – 2026
Chart 6 12: Self-Expanding Bare-Metal Stent Market, U.S., 2016 – 2026
Chart 6 13: Balloon-Expanding Bare-Metal Stent Market, U.S., 2016 – 2026
Chart 6 14: Covered Stent Market by Segment, U.S., 2016 – 2026
Chart 6 15: Total Covered Stent Market, U.S., 2016 – 2026
Chart 6 16: Iliac Covered Stent Market, U.S., 2016 – 2026
Chart 6 17: Fem- Popliteal Covered Stent Market, U.S., 2016 – 2026
Chart 6 18: AV Access Covered Stent Market, U.S., 2016 – 2026
Chart 6 19: Drug-Eluting Stent Market by Segment, U.S., 2016 – 2026
Chart 6 20: Total Drug-Eluting Stent Market, U.S., 2016 – 2026
Chart 6 21: SFA Drug-Eluting Stent Market, U.S., 2016 – 2026
Chart 6 22: Infra-Popliteal Drug-Eluting Stent Market, U.S., 2016 – 2026
Chart 6 23: Units Sold by Stent Length, Bare-Metal Carotid Stent Market, U.S., 2016 – 2026
Chart 6 24: Units Sold by Stent Length, Bare-Metal Renal Stent Market, U.S., 2016 – 2026
Chart 6 25: Units Sold by Stent Length, Bare-Metal Iliac Stent Market, U.S., 2016 – 2026
Chart 6 26: Units Sold by Stent Length, Bare-Metal Fem-Popliteal Stent Market, U.S., 2016 – 2026
Chart 6 27: Leading Competitors, Peripheral Vascular Stent Market, U.S., 2019
Chart 6 28: Leading Competitors, Bare-Metal Stent Market, U.S., 2019
Chart 6 29: Leading Competitors, Bare-Metal Stent Market by Delivery Platform, U.S., 2019
Chart 6 30: Leading Competitors, Bare-Metal Stent Market by Delivery Platform, U.S., 2019
Chart 6 31: Leading Competitors, Drug-Eluting Stent Market by Indication, U.S., 2019
Chart 7 1: Venous Stent Market, U.S., 2016 – 2026
Chart 7 2: Leading Competitors, Venous Stent Market, U.S., 2019
Chart 8 1: PTA Balloon Catheter Market by Segment, U.S., 2016 – 2026
Chart 8 2: PTA Balloon Catheter Market Breakdown, U.S., 2019
Chart 8 3: PTA Balloon Catheter Market Breakdown, U.S., 2026
Chart 8 4: Total PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 5: Standard PTA Balloon Catheter Market by Segment, U.S., 2016 – 2026
Chart 8 6: Total Standard PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 7: Hospital Standard PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 8: Office-Based Lab Standard PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 9: High-Pressure PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 10: Large PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 11: Small PTA Balloon Catheter Market by Segment, U.S., 2016 – 2026
Chart 8 12: Total Small PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 13: 0.014” Small PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 14: 0.018” Small PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 15: Specialty PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 16: Units Sold by Application, PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 17: Leading Competitors, PTA Balloon Market, U.S., 2019
Chart 9 1: Drug-Coated Balloon Market by Segment, U.S., 2016 – 2026
Chart 9 2: Drug-Coated Balloon Market Breakdown, U.S., 2019
Chart 9 3: Drug-Coated Balloon Market Breakdown, U.S., 2026
Chart 9 4: SFA DCB Market, U.S., 2016 – 2026
Chart 9 5: BTK DCB Market, U.S., 2016 – 2026
Chart 9 6: AV Access DCB Market, U.S., 2016 – 2026
Chart 9 7: Units Sold by Sheath Size, Drug-Coated Balloon Market, U.S., 2016 – 2026
Chart 9 8: Units Sold by Balloon Diameter, Drug-Coated Balloon Market, U.S., 2016 – 2026
Chart 9 9: Units Sold by Balloon Length, Drug-Coated Balloon Market, U.S., 2016 – 2026
Chart 9 10: Units Sold by Shaft Length, Drug-Coated Balloon Market, U.S., 2016 – 2026
Chart 9 11: Units Sold by Rated Burst Pressure, Drug-Coated Balloon Market, U.S., 2016 – 2026
Chart 9 12: Units Sold by Care Setting, Drug-Coated Balloon Market, U.S., 2016 – 2026
Chart 9 13: Leading Competitors, Drug-Coated Balloon Market, U.S., 2019
Chart 10 1: Atherectomy Device Market by Segment, U.S., 2016 – 2026
Chart 10 2: Atherectomy Device Market Breakdown by Segment, U.S., 2019
Chart 10 3: Atherectomy Device Market Breakdown by Segment, U.S., 2026
Chart 10 4: Laser Atherectomy Device Market by Segment, U.S., 2016 – 2026
Chart 10 5: Laser Atherectomy Console Market, U.S., 2016 – 2026
Chart 10 6: Laser Atherectomy Disposable Market, U.S., 2016 – 2026
Chart 10 7: Mechanical Atherectomy Disposable Market, U.S., 2016 – 2026
Chart 10 8: Atherectomy Disposables Market by Setting, U.S., 2016 – 2026
Chart 10 9: Hospital Atherectomy Disposables Market, U.S., 2016 – 2026
Chart 10 10: Office-Based Lab Atherectomy Disposables Market, U.S., 2016 – 2026
Chart 10 11: Leading Competitors, Atherectomy Device Market, U.S., 2019
Chart 11 1: Intravascular Lithotripsy Market, U.S., 2016 – 2026
Chart 11 2: Intravascular Lithotripsy Units Sold by Diameter, U.S., 2019
Chart 12 1: CTO Device Market by Segment, U.S., 2016 – 2026
Chart 12 2: CTO Device Market Breakdown, U.S., 2019
Chart 12 3: CTO Device Market Breakdown, U.S., 2026
Chart 12 4: Total CTO Device Market, U.S., 2016 – 2026
Chart 12 5: Re-Entry Device Market, U.S., 2016 – 2026
Chart 12 6: Re-Canalization Device Market, U.S., 2016 – 2026
Chart 12 7: Leading Competitors, CTO Device Market, U.S., 2019
Chart 13 1: Surgical Graft Market by Indication, U.S., 2016 – 2026
Chart 13 2: Surgical Graft Market Breakdown by Indication, U.S., 2019
Chart 13 3: Surgical Graft Market Breakdown by Indication, U.S., 2026
Chart 13 4: Surgical Graft Market by Material, U.S., 2016 – 2026
Chart 13 5: Surgical Graft Market Breakdown by Material, U.S., 2019
Chart 13 6: Surgical Graft Market Breakdown by Material, U.S., 2026
Chart 13 7: Total Surgical Graft Market, U.S., 2016 – 2026
Chart 13 8: Lower Limb Surgical Graft Market by Segment, U.S., 2016 – 2026
Chart 13 9: Total Lower Limb Surgical Graft Market, U.S., 2016 – 2026
Chart 13 10: Above-the-Knee Surgical Graft Market, U.S., 2016 – 2026
Chart 13 11: Below-the-Knee Surgical Graft Market, U.S., 2016 – 2026
Chart 13 12: Aorta Repair Surgical Graft Market by Segment, U.S., 2016 – 2026
Chart 13 13: Total Aorta Repair Surgical Graft Market, U.S., 2016 – 2026
Chart 13 14: Abdominal Aortic Surgical Graft Market, U.S., 2016 – 2026
Chart 13 15: Thoracic Aortic Surgical Graft Market, U.S., 2016 – 2026
Chart 13 16: Extra-Anatomical Bypass Surgical Graft Market, U.S., 2016 – 2026
Chart 13 17: Polyester Surgical Graft Market, U.S., 2016 – 2026
Chart 13 18: ePTFE Surgical Graft Market, U.S., 2016 – 2026
Chart 13 19: Leading Competitors, Surgical Graft Market, U.S., 2019
Chart 14 1: Stent Graft Market by Segment, U.S., 2016 – 2026
Chart 14 2: Stent Graft Market Breakdown, U.S., 2019
Chart 14 3: Stent Graft Market Breakdown, U.S., 2026
Chart 14 4: Total Stent Graft Market, U.S., 2016 – 2026
Chart 14 5: AAA Stent Graft Market by Segment, U.S., 2016 – 2026
Chart 14 6: Total AAA Stent Graft Market, U.S., 2016 – 2026
Chart 14 7: Bifurcated Main Body Graft Market, U.S., 2016 – 2026
Chart 1 1: Peripheral Vascular Device Market by Segment, U.S., 2016 – 2026
Chart 1 2: Peripheral Vascular Device Market Overview, U.S., 2019 & 2026
Chart 4 1: Peripheral Vascular Device Market by Segment, U.S., 2016 – 2026
Chart 4 2: Peripheral Vascular Device Market Breakdown, U.S., 2019
Chart 4 3: Peripheral Vascular Device Market Breakdown, U.S., 2026
Chart 4 4: Growth Rates by Segment, Peripheral Vascular Device Market, U.S., 2017 – 2026
Chart 4 5: Leading Competitors, Peripheral Vascular Device Market, U.S., 2020
Chart 5 1: Peripheral Vascular Procedures by Type, U.S., 2016 – 2026
Chart 5 2: Stenting Procedures by Stent Type, U.S., 2016 – 2026
Chart 5 3: Bare-Metal Stent Procedures by Delivery Method, U.S., 2016 – 2026
Chart 5 4: Bare-Metal Stent Procedures by Indication, U.S., 2016 – 2026
Chart 5 5: Covered Stent Procedures by Indication, U.S., 2016 – 2026
Chart 5 6: Drug-Eluting Stent Procedures by Indication, U.S., 2016 – 2026
Chart 5 7: Peripheral Venous Stent Procedures, U.S., 2016 – 2026
Chart 5 8: PTA Balloon Catheter Procedures, U.S., 2016 – 2026
Chart 5 9: Drug-Coated Balloon Procedures by Indication, U.S., 2016 – 2026
Chart 5 10: Drug-Coated Balloon Procedures by Care Setting, U.S., 2016 – 2026
Chart 5 11: Atherectomy Procedures by Device Type, U.S., 2016 – 2026
Chart 5 12: Atherectomy Procedures by Indication, U.S., 2016 – 2026
Chart 5 13: Fem-Popliteal Artery Atherectomy Procedures by Type, U.S., 2016 – 2026
Chart 5 14: Infra-Popliteal Artery Atherectomy Procedures by Type, U.S., 2016 – 2026
Chart 5 15: Intravascular Lithotripsy Procedures by Indication, U.S., 2016 – 2026
Chart 5 16: CTO Device Procedures by Type, U.S., 2016 – 2026
Chart 5 17: Surgical Graft Procedures by Graft Material, U.S., 2016 – 2026
Chart 5 18: Surgical Graft Procedures by Indication, U.S., 2016 – 2026
Chart 5 19: Lower Limb Surgical Graft Procedures by Anatomy, U.S., 2016 – 2026
Chart 5 20: Aorta Repair Surgical Graft Procedures by Anatomy, U.S., 2016 – 2026
Chart 5 21: Endovascular Stent Graft Procedures by Type, U.S., 2016 – 2026
Chart 5 22: EVAR Procedures by Anatomy, U.S., 2019
Chart 5 23: EVAR Procedures by Complexity, U.S., 2016 – 2026
Chart 5 24: EVAR Procedures by Fenestration, U.S., 2016 – 2026
Chart 5 25: EVAR Procedures by Anesthesia Type, U.S., 2016 – 2026
Chart 5 26: EVAR Procedures by Gender, U.S., 2016 – 2026
Chart 5 27: TEVAR Procedures by Indication, U.S., 2019
Chart 5 28: TEVAR Procedures by Gender, U.S., 2016 – 2026
Chart 5 29: Embolic Protection Procedures by Type, U.S., 2016 – 2026
Chart 5 30: Peripheral Thrombus Management Procedures by Procedure Type, U.S., 2016 – 2026
Chart 5 31: Peripheral Thrombus Management Procedures by Indication, U.S., 2016 – 2026
Chart 5 32: Inferior Vena Cava Filter Procedures by Procedure Type, U.S., 2016 – 2026
Chart 5 33: Transcarotid Artery Revascularization Procedures, U.S., 2016 – 2026
Chart 5 34: Vascular Closure Procedures by Device Type, U.S., 2016 – 2026
Chart 5 35: Invasive Vascular Closure Procedures by Device Size, U.S., 2016 – 2026
Chart 5 36: Vascular Closure Procedures by Approach, U.S., 2016 – 2026
Chart 5 37: Transcatheter Embolization Procedures by Device Type, U.S., 2016 – 2026
Chart 5 38: Transcatheter Particle Embolization Procedures by Device Type, U.S., 2016 – 2026
Chart 5 39: Transcatheter Coil Embolization Procedures by Device Type, U.S., 2016 – 2026
Chart 5 40: Peripheral IVUS Procedures by Indication, U.S., 2016 – 2026
Chart 6 1: Peripheral Vascular Stent Market by Segment, U.S., 2016 – 2026
Chart 6 2: Peripheral Vascular Stent Market Breakdown, U.S., 2019
Chart 6 3: Peripheral Vascular Stent Market Breakdown, U.S., 2026
Chart 6 4: Total Bare-Metal Peripheral Arterial Stent Market, U.S., 2016 – 2026
Chart 6 5: Bare-Metal Stent Market by Indication, U.S., 2016 – 2026
Chart 6 6: Bare-Metal Carotid Stent Market, U.S., 2016 – 2026
Chart 6 7: Bare-Metal Renal Stent Market, U.S., 2016 – 2026
Chart 6 8: Bare-Metal Iliac Stent Market, U.S., 2016 – 2026
Chart 6 9: Bare-Metal Fem-Popliteal Stent Market, U.S., 2016 – 2026
Chart 6 10: Bare-Metal Infra-Popliteal Stent Market, U.S., 2016 – 2026
Chart 6 11: Bare-Metal Stent Market by Delivery Platform, U.S., 2016 – 2026
Chart 6 12: Self-Expanding Bare-Metal Stent Market, U.S., 2016 – 2026
Chart 6 13: Balloon-Expanding Bare-Metal Stent Market, U.S., 2016 – 2026
Chart 6 14: Covered Stent Market by Segment, U.S., 2016 – 2026
Chart 6 15: Total Covered Stent Market, U.S., 2016 – 2026
Chart 6 16: Iliac Covered Stent Market, U.S., 2016 – 2026
Chart 6 17: Fem- Popliteal Covered Stent Market, U.S., 2016 – 2026
Chart 6 18: AV Access Covered Stent Market, U.S., 2016 – 2026
Chart 6 19: Drug-Eluting Stent Market by Segment, U.S., 2016 – 2026
Chart 6 20: Total Drug-Eluting Stent Market, U.S., 2016 – 2026
Chart 6 21: SFA Drug-Eluting Stent Market, U.S., 2016 – 2026
Chart 6 22: Infra-Popliteal Drug-Eluting Stent Market, U.S., 2016 – 2026
Chart 6 23: Units Sold by Stent Length, Bare-Metal Carotid Stent Market, U.S., 2016 – 2026
Chart 6 24: Units Sold by Stent Length, Bare-Metal Renal Stent Market, U.S., 2016 – 2026
Chart 6 25: Units Sold by Stent Length, Bare-Metal Iliac Stent Market, U.S., 2016 – 2026
Chart 6 26: Units Sold by Stent Length, Bare-Metal Fem-Popliteal Stent Market, U.S., 2016 – 2026
Chart 6 27: Leading Competitors, Peripheral Vascular Stent Market, U.S., 2019
Chart 6 28: Leading Competitors, Bare-Metal Stent Market, U.S., 2019
Chart 6 29: Leading Competitors, Bare-Metal Stent Market by Delivery Platform, U.S., 2019
Chart 6 30: Leading Competitors, Bare-Metal Stent Market by Delivery Platform, U.S., 2019
Chart 6 31: Leading Competitors, Drug-Eluting Stent Market by Indication, U.S., 2019
Chart 7 1: Venous Stent Market, U.S., 2016 – 2026
Chart 7 2: Leading Competitors, Venous Stent Market, U.S., 2019
Chart 8 1: PTA Balloon Catheter Market by Segment, U.S., 2016 – 2026
Chart 8 2: PTA Balloon Catheter Market Breakdown, U.S., 2019
Chart 8 3: PTA Balloon Catheter Market Breakdown, U.S., 2026
Chart 8 4: Total PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 5: Standard PTA Balloon Catheter Market by Segment, U.S., 2016 – 2026
Chart 8 6: Total Standard PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 7: Hospital Standard PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 8: Office-Based Lab Standard PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 9: High-Pressure PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 10: Large PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 11: Small PTA Balloon Catheter Market by Segment, U.S., 2016 – 2026
Chart 8 12: Total Small PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 13: 0.014” Small PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 14: 0.018” Small PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 15: Specialty PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 16: Units Sold by Application, PTA Balloon Catheter Market, U.S., 2016 – 2026
Chart 8 17: Leading Competitors, PTA Balloon Market, U.S., 2019
For a full Table of Contents, please contact iData
List of Figures
Figure 1 1: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2019 (1 of 4)
Figure 1 2: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2019 (2 of 4)
Figure 1 3: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2019 (3 of 4)
Figure 1 4: Peripheral Vascular Device Market Share Ranking by Segment, U.S., 2019 (4 of 4)
Figure 1 5: Companies Researched in this Report, U.S., 2019 (1 of 2)
Figure 1 6: Companies Researched in this Report, U.S., 2019 (2 of 2)
Figure 1 7: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (1 of 3)
Figure 1 8: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (2 of 3)
Figure 1 9: Factors Impacting the Peripheral Vascular Device Market by Segment, U.S. (3 of 3)
Figure 1 10: Recent Events in the Peripheral Vascular Market, U.S., 2016 – 2019
Figure 1 11: Peripheral Vascular Procedures Covered by Indication, Intervention & Care Setting, U.S. (1 of 3)
Figure 1 12: Peripheral Vascular Procedures Covered by Indication, Intervention & Care Setting, U.S. (2 of 3)
Figure 1 13: Peripheral Vascular Procedures Covered by Indication, Intervention & Care Setting, U.S. (3 of 3)
Figure 1 14: Peripheral Vascular Procedures Covered, U.S. (1 of 5)
Figure 1 15: Peripheral Vascular Procedures Covered, U.S. (2 of 5)
Figure 1 16: Peripheral Vascular Procedures Covered, U.S. (3 of 5)
Figure 1 17: Peripheral Vascular Procedures Covered, U.S. (4 of 5)
Figure 1 18: Peripheral Vascular Procedures Covered, U.S. (5 of 5)
Figure 1 19: Procedure Codes Investigated, U.S.
Figure 1 20: Peripheral Vascular Device Markets Covered, U.S. (1 of 8)
Figure 1 21: Peripheral Vascular Device Markets Covered, U.S. (2 of 8)
Figure 1 22: Peripheral Vascular Device Markets Covered, U.S. (3 of 8)
Figure 1 23: Peripheral Vascular Device Markets Covered, U.S. (4 of 8)
Figure 1 24: Peripheral Vascular Device Markets Covered, U.S. (5 of 8)
Figure 1 25: Peripheral Vascular Device Markets Covered, U.S. (6 of 8)
Figure 1 26: Peripheral Vascular Device Markets Covered, U.S. (7 of 8)
Figure 1 27: Peripheral Vascular Device Markets Covered, U.S. (8 of 8)
Figure 1 28: Key Report Updates
Figure 1 29: Version History
Figure 3 1: Peripheral Vascular Stent by Company (1 of 2)
Figure 3 2: Peripheral Vascular Stent by Company (2 of 2)
Figure 3 3: Venous Stent by Company
Figure 3 4: PTA Balloon Catheter by Company (1 of 3)
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook